Anti-inflammatory effects of linezolid on carrageenan-induced paw edema in rats

Kazuaki Matsumoto, Shigeaki Obara, Yuko Kuroda, Junko Kizu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The immunomodulatory activity of linezolid has recently been reported using in vitro experimental models. However, the anti-inflammatory activity of linezolid has not yet been demonstrated using in vivo experimental models. Therefore, the aim of the present study was to demonstrate the anti-inflammatory activity of linezolid and other anti-MRSA agents using the carrageenan-induced rat paw edema model.The pretreatment with 50 mg/kg linezolid significantly suppressed edema rates, compared with control (5% glucose), with edema rates at 0.5 and 3 h after the administration of carrageenan being 17.3 ± 3.5 and 30.8 ± 3.0%, respectively. On the other hand, edema rates were not suppressed by the pretreatments with 50 mg/kg vancomycin, teicoplanin, arbekacin, and daptomycin. Furthermore, we demonstrated that linezolid exhibited anti-inflammatory activity in a concentration-dependent manner. These effects were observed at linezolid concentrations that are achievable in human serum with conventional dosing.In conclusion, the results of the present study suggest that the anti-inflammatory activities of linezolid, in addition to its antimicrobial effects, have a protective effect against destructive inflammatory responses in areas of inflammation.

Original languageEnglish
Pages (from-to)889-891
Number of pages3
JournalJournal of Infection and Chemotherapy
Volume21
Issue number12
DOIs
Publication statusPublished - 2015 Dec 1

Fingerprint

Linezolid
Carrageenan
Edema
Anti-Inflammatory Agents
Theoretical Models
Daptomycin
Teicoplanin
Vancomycin
Methicillin-Resistant Staphylococcus aureus

Keywords

  • Anti-inflammatory activity
  • Carrageenan
  • Linezolid
  • Paw edema

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Anti-inflammatory effects of linezolid on carrageenan-induced paw edema in rats. / Matsumoto, Kazuaki; Obara, Shigeaki; Kuroda, Yuko; Kizu, Junko.

In: Journal of Infection and Chemotherapy, Vol. 21, No. 12, 01.12.2015, p. 889-891.

Research output: Contribution to journalArticle

Matsumoto, Kazuaki ; Obara, Shigeaki ; Kuroda, Yuko ; Kizu, Junko. / Anti-inflammatory effects of linezolid on carrageenan-induced paw edema in rats. In: Journal of Infection and Chemotherapy. 2015 ; Vol. 21, No. 12. pp. 889-891.
@article{f03dea6fc20a470889a5c8a2da999f18,
title = "Anti-inflammatory effects of linezolid on carrageenan-induced paw edema in rats",
abstract = "The immunomodulatory activity of linezolid has recently been reported using in vitro experimental models. However, the anti-inflammatory activity of linezolid has not yet been demonstrated using in vivo experimental models. Therefore, the aim of the present study was to demonstrate the anti-inflammatory activity of linezolid and other anti-MRSA agents using the carrageenan-induced rat paw edema model.The pretreatment with 50 mg/kg linezolid significantly suppressed edema rates, compared with control (5{\%} glucose), with edema rates at 0.5 and 3 h after the administration of carrageenan being 17.3 ± 3.5 and 30.8 ± 3.0{\%}, respectively. On the other hand, edema rates were not suppressed by the pretreatments with 50 mg/kg vancomycin, teicoplanin, arbekacin, and daptomycin. Furthermore, we demonstrated that linezolid exhibited anti-inflammatory activity in a concentration-dependent manner. These effects were observed at linezolid concentrations that are achievable in human serum with conventional dosing.In conclusion, the results of the present study suggest that the anti-inflammatory activities of linezolid, in addition to its antimicrobial effects, have a protective effect against destructive inflammatory responses in areas of inflammation.",
keywords = "Anti-inflammatory activity, Carrageenan, Linezolid, Paw edema",
author = "Kazuaki Matsumoto and Shigeaki Obara and Yuko Kuroda and Junko Kizu",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.jiac.2015.08.004",
language = "English",
volume = "21",
pages = "889--891",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "12",

}

TY - JOUR

T1 - Anti-inflammatory effects of linezolid on carrageenan-induced paw edema in rats

AU - Matsumoto, Kazuaki

AU - Obara, Shigeaki

AU - Kuroda, Yuko

AU - Kizu, Junko

PY - 2015/12/1

Y1 - 2015/12/1

N2 - The immunomodulatory activity of linezolid has recently been reported using in vitro experimental models. However, the anti-inflammatory activity of linezolid has not yet been demonstrated using in vivo experimental models. Therefore, the aim of the present study was to demonstrate the anti-inflammatory activity of linezolid and other anti-MRSA agents using the carrageenan-induced rat paw edema model.The pretreatment with 50 mg/kg linezolid significantly suppressed edema rates, compared with control (5% glucose), with edema rates at 0.5 and 3 h after the administration of carrageenan being 17.3 ± 3.5 and 30.8 ± 3.0%, respectively. On the other hand, edema rates were not suppressed by the pretreatments with 50 mg/kg vancomycin, teicoplanin, arbekacin, and daptomycin. Furthermore, we demonstrated that linezolid exhibited anti-inflammatory activity in a concentration-dependent manner. These effects were observed at linezolid concentrations that are achievable in human serum with conventional dosing.In conclusion, the results of the present study suggest that the anti-inflammatory activities of linezolid, in addition to its antimicrobial effects, have a protective effect against destructive inflammatory responses in areas of inflammation.

AB - The immunomodulatory activity of linezolid has recently been reported using in vitro experimental models. However, the anti-inflammatory activity of linezolid has not yet been demonstrated using in vivo experimental models. Therefore, the aim of the present study was to demonstrate the anti-inflammatory activity of linezolid and other anti-MRSA agents using the carrageenan-induced rat paw edema model.The pretreatment with 50 mg/kg linezolid significantly suppressed edema rates, compared with control (5% glucose), with edema rates at 0.5 and 3 h after the administration of carrageenan being 17.3 ± 3.5 and 30.8 ± 3.0%, respectively. On the other hand, edema rates were not suppressed by the pretreatments with 50 mg/kg vancomycin, teicoplanin, arbekacin, and daptomycin. Furthermore, we demonstrated that linezolid exhibited anti-inflammatory activity in a concentration-dependent manner. These effects were observed at linezolid concentrations that are achievable in human serum with conventional dosing.In conclusion, the results of the present study suggest that the anti-inflammatory activities of linezolid, in addition to its antimicrobial effects, have a protective effect against destructive inflammatory responses in areas of inflammation.

KW - Anti-inflammatory activity

KW - Carrageenan

KW - Linezolid

KW - Paw edema

UR - http://www.scopus.com/inward/record.url?scp=84947485426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947485426&partnerID=8YFLogxK

U2 - 10.1016/j.jiac.2015.08.004

DO - 10.1016/j.jiac.2015.08.004

M3 - Article

VL - 21

SP - 889

EP - 891

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 12

ER -